Preview

Russian Journal of Cardiology

Advanced search

CLINICIAN — TREATS, AND PATIENT — BEING TREATED? RECENT VIEW ON THE TREATMENT ADHERENCE IN CORONARY HEART DISEASE SETTING

https://doi.org/10.15829/1560-4071-2017-9-104-108

Abstract

The literary review includes data from recent research on the medication and nonmedication treatment adherence of coronary heart disease patients. The various approaches considered, of the adherence improvement, and psychological models presented, the “information-motivation-strategy” and “transtheoretical model”. The polypill phenomenon is considered. Also three terms on adherence are commented: compliance, concordance and adherence itself, depending on the part of patient’s active role.

About the Authors

О. Yu. Shaydyuk
N.I. Pirogov Russian National Research Medical University (RNRMU)
Russian Federation


М. А. Kudinova
O.M. Filatov City Clinical Hospital № 15


Е. О. Taratukhin 
N.I. Pirogov Russian National Research Medical University (RNRMU)


О. V. Romashenko
O.M. Filatov City Clinical Hospital № 15


References

1. McKay C. D., Verhagen E. 'Compliance' versus 'adherence' in sport injury prevention: why definition matters. British Journal of Sports Medicine, 2016; 50(7):382-U1 - 10.1136/bjsports-2015-095192

2. Catapano A. L., Graham I., De Backer G., et al. 2016 ESC/EAS Guidelines for the Management of Dyslipidaemias. Eur Heart J, 2016; 37(39):2999-3058 - 10.1093/eurheartj/ehw272

3. Pardaens S., De Smedt D., De Bacquer D., et al. Comorbidities and Psychosocial Characteristics as Determinants of Dropout in Outpatient Cardiac Rehabilitation. The Journal of cardiovascular nursing, 2017; 32(1):14-21 - 10.1097/jcn.0000000000000296

4. Park L. G., Schopfer D. W., Zhang N., et al. Participation in Cardiac Rehabilitation Among Patients With Heart Failure. Journal of cardiac failure, 2017; - 10.1016/j.cardfail.2017.02.003

5. Abegaz T. M., Shehab A., Gebreyohannes E. A., et al. Nonadherence to antihypertensive drugs: A systematic review and meta-analysis. Medicine, 2017; 96(4):e5641 - 10.1097/md.0000000000005641

6. Salari A., Hasandokht T., Mahdavi-Roshan M., et al. Risk factor control, adherence to medication and follow up visit, five years after coronary artery bypass graft surgery. Journal of cardiovascular and thoracic research, 2016; 8(4):152-7 - 10.15171/jcvtr.2016.31

7. Banach M., Stulc T., Dent R., et al. Statin non-adherence and residual cardiovascular risk: There is need for substantial improvement. International Journal of Cardiology, 2016; 225184-96 - 10.1016/j.ijcard.2016.09.075

8. Krahenbuhl S., Pavik-Mezzour I., von Eckardstein A. Unmet Needs in LDL-C Lowering: When Statins Won't Do! Drugs, 2016; 76(12):1175-90 - 10.1007/s40265-016-0613-0

9. Stroes E. S., Thompson P. D., Corsini A., et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. European Heart Journal, 2015; 36(17):1012-22B - 10.1093/eurheartj/ehv043

10. Goldstein K. M., Zullig L. L., Bastian L. A., et al. Statin Adherence: Does Gender Matter? Current Atherosclerosis Reports, 2016; 18(11): - 10.1007/s11883-016-0619-9

11. Serban M. C., Colantonio L. D., Manthripragada A. D., et al. Statin Intolerance and Risk of Coronary Heart Events and All-Cause Mortality Following Myocardial Infarction. J Am Coll Cardiol, 2017; 69(11):1386-95 - 10.1016/j.jacc.2016.12.036

12. Maggioni A. P., Calabria S., Rossi E., et al. Use of lipid lowering drugs in patients at very high risk of cardiovascular events: An analysis on nearly 3,000,000 Italian subjects of the ARNO Observatory. Int J Cardiol, 2017; - 10.1016/j.ijcard.2017.02.108

13. Sluyter J. D., Hughes A. D., Lowe A., et al. Statin utilisation in a real-world setting: a retrospective analysis in relation to arterial and cardiovascular autonomic function. Pharmacology research & perspectives, 2016; 4(6):e00276 - 10.1002/prp2.276

14. Yu J., Baber U., Mastoris I., et al. Sex-Based Differences in Cessation of Dual-Antiplatelet Therapy Following Percutaneous Coronary Intervention With Stents. JACC Cardiovascular interventions, 2016; 9(14):1461-9 - 10.1016/j.jcin.2016.04.004

15. Swieczkowski D., Mogielnicki M., Cwalina N., et al. Medication adherence in patients after percutaneous coronary intervention due to acute myocardial infarction: From research to clinical implications. Cardiology journal, 2016; - 10.5603/CJ.a2016.0048

16. Prami T., Khanfir H., Deleskog A., et al. Clinical factors associated with initiation of and persistence with ADP receptor-inhibiting oral antiplatelet treatment after acute coronary syndrome: a nationwide cohort study from Finland. BMJ Open, 2016; 6(11):e012604 - 10.1136/bmjopen-2016-012604

17. Bonaccio M., Bes-Rastrollo M., de Gaetano G., et al. Challenges to the Mediterranean diet at a time of economic crisis. Nutrition Metabolism and Cardiovascular Diseases, 2016; 26(12):1057-63 - 10.1016/j.numecd.2016.07.005

18. Bakker E. C., Nijkamp M. D., Sloot C., et al. Intention to Abstain From Smoking Among Cardiac Rehabilitation Patients The Role of Attitude, Self-efficacy, and Craving. Journal of Cardiovascular Nursing, 2015; 30(2):172-9 - 10.1097/jcn.0000000000000156

19. Kwasnicka D., Dombrowski S. U., White M., et al. N-of-1 study of weight loss maintenance assessing predictors of physical activity, adherence to weight loss plan and weight change. Psychol Health, 2017; 32(6):686-708 - 10.1080/08870446.2017.1293057

20. Prochaska J. J., Benowitz N. L. Smoking cessation and the cardiovascular patient. Current Opinion in Cardiology, 2015; 30(5):506-11 - 10.1097/hco.0000000000000204

21. Davydov EL, Kharkov EI, Shapiro LA. The features of commitment to the treatment of patients with arterial hypertension in the older age groups depending on the level of education. Siberian Medical Review, 2012; 75(3):65-7 (Russian: Давыдов Е.Л., Харьков Е.И., Шапиро Л.А. Особенности приверженности к терапии пациентов с артериальной гипертонией старших возрастных групп в зависимости от уровня образования. Сибирское медицинское обозрение, 2012; 75(3):65-7)

22. Konradi AO, Polunicheva EV. Insufficient adherence to arterial hypertension treatment: cuses and approaches for correction. Arterial Hypertension, 2004; 10(3): 137-43 (Russian: Конради А.О., Полуничева Е.В. Недостаточная приверженность к лечению артериальной гипертензии: причины и пути коррекции. Артериальная гипертензия, 2004; 10(3):137-43)

23. Lukina Yu.V., Kutishenko N.P., Dmitrieva NA, et al. Compliance to clinician prescriptions in ischemic heart disease patients (by the data from outpatient registry PROFILE). Russian Journal of Cardiology, 2017; 143(3):14-19 (Russian: Лукина ЮВ, Кутишенко НП, НА Дмитриева, et al. Приверженность больных хронической ишемической болезнью сердца врачебным рекомендациям (по данным регистра ПРОФИЛЬ). Российский кардиологический журнал, 2017; 143(3):14-9)

24. Cavicchioli M. G. S., Guerbali C. C. L., Ochiai C., et al. The Contribution of Diabetes Education in the Treatment of People with Type 2 Diabetes and Risk of Cardiovascular Disease. Current Atherosclerosis Reports, 2016; 18(7): - 10.1007/s11883-016-0591-4

25. Nord J. W., Jr., Berry A., Stults B., et al. Evaluation of the Effectiveness of a Patient-Centered Educational Mailer Designed to Improve Statin Adherence: A Pragmatic Trial. EGEMS (Washington, DC), 2016; 4(1):1256 - 10.13063/2327-9214.1256

26. Schondube A., Bertrams A., Sudeck G., et al. Self-control strength and physical exercise: An ecological momentary assessment study. Psychology of Sport and Exercise, 2017; 2919-26 - 10.1016/j.psychsport.2016.11.006

27. Wienert J., Gellert P., Lippke S. Physical activity across the life-span: Does feeling physically younger help you to plan physical activities? Journal of Health Psychology, 2017; 22(3):324-35 - 10.1177/1359105315603469

28. Schwarzer R. Health Behavior Change. In: Friedman, H, editor. The Oxford Handbook of Health Psychology. UK: OUP; 2011. p. 591-611.

29. Librero J., Sanfelix-Gimeno G., Peiro S. Medication Adherence Patterns after Hospitalization for Coronary Heart Disease. A Population-Based Study Using Electronic Records and Group-Based Trajectory Models. PLoS One, 2016; 11(8):e0161381 - 10.1371/journal.pone.0161381

30. Webster R., Rodgers A. Polypill treatments for cardiovascular diseases. Expert Opin Drug Deliv, 2016; 13(1):1-6 - 10.1517/17425247.2016.1111869

31. Bramlage P., Sims H., Minguet J., et al. The polypill: An effective approach to increasing adherence and reducing cardiovascular event risk. Eur J Prev Cardiol, 2017; 24(3):297-310 - 10.1177/2047487316674817

32. Koh J. S., Park Y., Tantry U. S., et al. Pharmacodynamic effects of a new fixed-dose clopidogrel-aspirin combination compared with separate administration of clopidogrel and aspirin in patients treated with coronary stents: The ACCEL-COMBO trial. Platelets, 2017; 28(2):187-93 - 10.1080/09537104.2016.1206197

33. Lim W. H., Chae I. H., Yoon C. H., et al. Comparison of dual antiplatelet therapy prescribed as one-pill versus two-pill regimen. A pooled analysis of individual patient data from the three MR-CAPCIS trials. Thrombosis and haemostasis, 2016; 116(1):78-86 - 10.1160/th15-12-0931

34. Martin Leslie R. Barriers and Keys to Treatment Adherence and Health Behavior Change. In: DiMatteo, MR, Martin, LR, editors. The Oxford Handbook of Health Communication, Behaviour Change and Treatment Adherence. UK: OUP; 2013. p. 10-20.

35. Taratukhin E.O. Biopsychosocial approach: a modern demand for interdisciplinarity. Russ J Cardiol, 2015; 125(9):80-3 - 10.15829/1560-4071-2015-09-80-83

36. Chauhan B. F., Jeyaraman M., Mann A. S., et al. Behavior change interventions and policies influencing primary healthcare professionals' practice-an overview of reviews. Implement Sci, 2017; 12(1):3 - 10.1186/s13012-016-0538-8

37. Taratukhin E. O., Kudinova M. A., Shaydyuk О Yu, et al. Person-Centered Interview as a Tool for Clinical Work in Myocardial Infarction Setting. Cardiovascular Therapy and Prevention, 2017; 16(1):34-9 - 10.15829/1728-8800-2017-1-34-39


Review

For citations:


Shaydyuk О.Yu., Kudinova М.А., Taratukhin  Е.О., Romashenko О.V. CLINICIAN — TREATS, AND PATIENT — BEING TREATED? RECENT VIEW ON THE TREATMENT ADHERENCE IN CORONARY HEART DISEASE SETTING. Russian Journal of Cardiology. 2017;(9):104-108. (In Russ.) https://doi.org/10.15829/1560-4071-2017-9-104-108

Views: 15221


Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 License.


ISSN 1560-4071 (Print)
ISSN 2618-7620 (Online)